FGFR3 and urinary bladder carcinoma: Cappellen et al. reported FGFR3 mutations in bladder cancer with a frequency of 35%, and subsequent studies established this frequency in approximately half of the primary bladder tumors (Cappellen et al., 1999; Sibley et al., 2001).